[
  {
    "ts": null,
    "headline": "1 Healthcare Stock with Exciting Potential and 2 Facing Challenges",
    "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 13.9% return has trailed the S&P 500 by 18.8 percentage points.",
    "url": "https://finnhub.io/api/news?id=2d4f4c64861ab1288967f6a6fcfe31f3dd08f2dddd748dcccbf5d560c66c7040",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759725756,
      "headline": "1 Healthcare Stock with Exciting Potential and 2 Facing Challenges",
      "id": 136989647,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 13.9% return has trailed the S&P 500 by 18.8 percentage points.",
      "url": "https://finnhub.io/api/news?id=2d4f4c64861ab1288967f6a6fcfe31f3dd08f2dddd748dcccbf5d560c66c7040"
    }
  }
]